BARR, KENNETH JAY,MACLEAN, JOHN,ZHANG, HONGJUN,BERESIS, RICHARD THOMAS,ANTHONY, NEVILLE,DANIELS, MATTHEW H,LAPOINTE, BLAIR,SCIAMMETTA, NUNZIO
申请号：
PL13829341
公开号：
PL2920149T3
申请日:
2013.08.14
申请国别(地区):
PL
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
